Table III.
Follow-up outcomes of patients in two groups
| Parameter | LESS-NU (n = 25) | RL-NU (n = 17) | P-value* |
|---|---|---|---|
| Follow-up, mean (SD) [months] | 31.57 (8.195) | 32.75 (10.506) | 0.722 |
| Follow-up persons, n | 21 | 12 | |
| Chemotherapy, n (%) | 18 (90) | 11 (91.67) | 0.876 |
| Tumor recurrence rate, n: | 5 | 3 | |
| Bladder recurrence, n (%) | 2 (9.52) | 1 (8.33) | |
| Pelvic metastasis, n (%) | 2 (9.52) | 1 (8.33) | |
| Bone metastasis, n (%) | 1 (4.76) | 1 (8.33) |